Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer’s disease-like pathology in the APPNL-G-F knock-in mouse model
Scientific Reports · 2024
DOI: 10.1038/s41598-024-78751-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Hadir E AlQot und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Robarts Research Institute, University of Western Ontario, London…. Hauptthemen laut MEDLINE: Alzheimer Disease, Choline O-Acetyltransferase, Disease Models, Animal, Mice, Transgenic. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is characterized by amyloidosis, neuroinflammation, cholinergic dysfunction and cognitive impairment. In AD, the cholinergic neuronal marker choline acetyltransferase (ChAT) is reduced and the primate-specific nuclear isoform, 82-kDa ChAT, is mislocalized to cytoplasm. Cell-based studies suggest a role for 82-kDa ChAT in regulating expression of AD-related genes with potential reductions in β-amyloid (Aβ) levels. To study this further, we crossed transgenic mice expressing human 82-kDa ChAT with the AD mouse model APPNL-G-F and used molecular techniques and neurobehavioral tests to study the impact of 82-kDa ChAT on AD pathology. These mice had altered expression of genes linked to Aβ clearance and inflammation, and reduced cognitive decline, amyloidosis and gliosis. These effects were inversely related to age and Aβ plaque load and correlated best with 82-kDa ChAT localized to nuclei of neurons. The study suggests a role for 82-kDa ChAT in decreasing AD-like pathology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Robarts Research Institute, University of Western Ontario, London, ON, N6A 5K8, Canada.
- Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Robarts Research Institute, University of Western Ontario, London, ON, N6A 5K8, Canada. jane.rylett@schulich.uwo.ca.
Förderung
- Canadian Institutes of Health Research
Zitieren
APA
AlQot, H. E., & Rylett, R. J. (2024). Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer’s disease-like pathology in the APPNL-G-F knock-in mouse model. Scientific Reports. https://doi.org/10.1038/s41598-024-78751-2
Vancouver
AlQot HE, Rylett RJ. Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer’s disease-like pathology in the APPNL-G-F knock-in mouse model. Scientific Reports. 2024. doi:10.1038/s41598-024-78751-2
BibTeX
@article{AlQot2024,
author = {AlQot, Hadir E and Rylett, Rebecca Jane},
title = {Primate-specific 82-kDa choline acetyltransferase attenuates progression of Alzheimer’s disease-like pathology in the APPNL-G-F knock-in mouse model},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-78751-2}
}
EUVIMED